We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App





Artificial Intelligence (AI) Tool Predicts Oxygen Need of Hospitalized COVID-19 Patients Anywhere in the World

By HospiMedica International staff writers
Posted on 16 Sep 2021
Print article
Illustration
Illustration
Researchers have used artificial intelligence (AI) to predict the oxygen needs of COVID-19 patients on a global scale.

Addenbrooke’s Hospital (Cambridge, England) along with 20 other hospitals from across the world and AI technology company NVIDIA (Santa Clara, CA, USA) have built an AI tool to predict how much extra oxygen a COVID-19 patient may need in the first days of hospital care, using data from across four continents. The technique, known as federated learning, used an algorithm to analyze chest X-rays and electronic health data from hospital patients with symptoms of COVID-19.

To maintain strict patient confidentiality, the patient data was fully anonymized and an algorithm was sent to each hospital so no data was shared or left its location. Once the algorithm had ‘learned’ from the data, the analysis was brought together to build an AI tool which could predict the oxygen needs of hospitalized COVID-19 patients anywhere in the world. The study dubbed EXAM (for EMR CXR AI Model), was one of the largest, most diverse clinical federated learning studies to date. To check the accuracy of EXAM, it was tested out in a number of hospitals across five continents. The outcomes of around 10,000 COVID patients from across the world were analyzed in the study. The results showed it predicted the oxygen needed within 24 hours of a patient’s arrival in the emergency department, with a sensitivity of 95% and a specificity of over 88%.

“Federated learning has transformative power to bring AI innovation to the clinical workflow,” said Professor Fiona Gilbert, who led the study. “Our continued work with EXAM demonstrates that these kinds of global collaborations are repeatable and more efficient, so that we can meet clinicians’ needs to tackle complex health challenges and future epidemics.”

“Usually in AI development, when you create an algorithm on one hospital’s data, it doesn’t work well at any other hospital,” said Dr. Ittai Dayan, first author on the study. “By developing the EXAM model using federated learning and objective, multimodal data from different continents, we were able to build a generalizable model that can help frontline physicians worldwide.”

Related Links:
Addenbrooke’s Hospital
NVIDIA


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Cylindrical Water Scanning System
SunSCAN 3D
New
4K-3D NIR/ICG Video Endoscope
TIPCAM 1 Rubina

Print article

Channels

Critical Care

view channel
Image: Mesenchymal stromal cells are delivered directly into the lungs using a bronchoscope (Photo courtesy of Stem Cell Res Ther. 2025. DOI: 10.1186/s13287-025-04289-3)

Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support

Until now, administering cell therapies to patients on extracorporeal membrane oxygenation (ECMO)—a life-support system typically used for severe lung failure—has been nearly impossible.... Read more

Surgical Techniques

view channel
Image: Intravascular imaging can improve outcomes for complex stenting procedures in patients with high-risk calcified coronary artery disease (Photo courtesy of Shutterstock)

Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures

Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.